Clinical Trials
2 trialsNCT05323890 2023-03-14
Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma.
Shandong Cancer Hospital and Institute
Phase 2 Unknown
NCT04437212 2020-06-26
Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer
RenJi Hospital
Phase 2 Unknown